Telehealth Ledger
bmiMD logoProvider treatment guide · checked 25 October 2026

bmiMD NAD+ injection

Published by Telehealth LedgerSource checked 25 October 2026

bmiMD lists NAD+ injection at $159 a month, continuing. Medication is included in that catalog price. Readers considering injectable NAD through bmiMD who need the injection's price basis kept separate from the nasal spray. The commercial terms were checked 25 October 2026; state access, clinician approval, dispensing details, and personal suitability remain separate questions.

We may earn a commission if you start a program through links on this page. It doesn't change prices or how we sort them. Disclosure

Visit bmiMD Affiliate link · we may earn a commissionRead the full review
bmiMD NAD+ injection treatment illustration
$159a month, continuing
Includedmedication in published price
Injectionlisted format
25 October 2026commercial terms checked
Not verifiedpublished state availability

compare bmiMD with other NAD+ injection prices

The short answer for this provider-treatment pair: bmiMD NAD+ injection

Evaluate bmiMD NAD+ injection on its own format and published schedule instead of treating nasal NAD as interchangeable.

Readers considering injectable NAD through bmiMD who need the injection's price basis kept separate from the nasal spray. A fair reading keeps bmiMD's NAD+ injection listing separate from adjacent products that may use a related medication or sit in the same provider catalog.

Do not blur this product with adjacent options: NAD+ injection

NAD+ injection is listed as a compounded product in Injection format. FDA states that compounded drugs are not FDA-approved and do not receive the same premarket review as approved drug products. Ask for the exact formulation and dispensing pharmacy before purchase. That status is central to this bmiMD guide because a related medication name does not make branded, compounded, oral, nasal, and injectable products interchangeable.

bmiMD lists NAD+ injection in Injection format. The Compounded NAD+ injection comparison groups offers with the same treatment and route so their prices can be assessed fairly. A shared medication name does not make different formulations interchangeable. This guide does not provide dose instructions or route conversions, and it does not establish that another formulation has the same evidence, safety profile, convenience or outcomes.

The published price and its terms: bmiMD

bmiMD lists NAD+ injection at $159 a month, continuing, checked 25 October 2026. Read the amount together with the billing interval and any promotion or prepayment shown beside it. A lower monthly equivalent may require a longer commitment and a larger charge today. The linked price source is dated evidence of the advertised offer, not an independently verified checkout total or a guarantee that every dose and plan costs the same.

The published price includes medication. It does not verify that labs, every consultation, supplies, expedited shipping, or future dose changes are included unless the source says so. Those items remain checkout questions. For bmiMD NAD+ injection, read medication inclusion as one part of the offer, not as proof that every service surrounding the prescription is free. The dated source establishes the advertised basis; it does not independently audit the final checkout, dispensing event, or quality of care.

Billing terms to settle before payment: bmiMD NAD+ injection

The published offer has both a continuing option at $159 a month, continuing and a prepaid option at $119 a month, paying $1,428 for 12 months up front. Those are different commitments. Compare the total charged today, the renewal path, and the cancellation deadline rather than treating the lowest monthly equivalent as month to month. For bmiMD's NAD+ injection offer, distinguish the introductory charge, continuing charge, upfront payment and required commitment. A monthly equivalent can be useful, but only when the required payment and term remain visible beside it.

The bmiMD price source for this offer was checked on 25 October 2026. Before paying for NAD+ injection, compare the amount charged today with the amount charged later, the number of months purchased, the renewal date, the cancellation window, and the refund boundary after clinical or pharmacy processing. A published price cannot safely answer those policy questions unless the cited provider evidence does.

Coverage, eligibility, and fulfillment: NAD+ injection

Telehealth Ledger has not verified nationwide availability for this nad offer. Missing state restrictions do not establish nationwide service. Confirm that this treatment can be prescribed and shipped to the actual state before intake. The NAD+ injection access check belongs near the price because a low published figure has little decision value when bmiMD cannot serve the reader's state or the selected product cannot be fulfilled there.

For bmiMD NAD+ injection, the consumer brand, administrative platform, clinical group, and dispensing pharmacy can be different entities. A provider page may describe a national service while licensure, product rules, and pharmacy coverage narrow actual fulfillment. Ask which clinician entity would review the intake and which licensed pharmacy would dispense this exact product in the reader's state before treating access as settled.

Who provides care and fulfills the order: bmiMD

The linked sources identify Medccm Inc dba bmiMD as bmiMD's administrator. The terms identify Medccm Inc, doing business as bmiMD, as the technology platform operator. Medccm Inc says it is not a healthcare provider and is not a HIPAA covered entity. These entities can perform different jobs, so the consumer-facing brand should not automatically be described as the clinician or dispensing pharmacy for NAD+ injection.

Age and U.S. customers: The terms say the Service is intended for U.S. customers and is available to individuals located in states where bmiMD offers the Service who are at least 18, or the age of majority if higher. An unresolved issue for bmiMD's NAD+ injection offer remains: Sermorelin injection $139 quarterly copy versus plan picker: The injection page says "Start for $139/month. Billed quarterly, shipped monthly" while the plan picker prices the 3-month plan at $357 ($119/mo). The catalog uses the plan-picker numbers. Ask the provider how that issue affects the selected order. A published price does not resolve uncertainty about billing, fulfillment, eligibility or the terms that apply after payment.

Compare prices across providers: NAD+ injection

The linked NAD+ injection comparison places bmiMD beside other providers with published prices. Check the same details for every offer: continuing price, introductory period, required prepayment, medication inclusion, product type, delivery format, verification date, and state evidence. If two offers use different routes or one price excludes medication, a simple lowest-number verdict would not be a like-for-like conclusion.

Use the comparison link to check other NAD+ injection offers, then open bmiMD's site to confirm the selected product. A provider may list several related treatments or plan lengths on the same page. Make sure the intake and checkout still name NAD+ injection, use the injection format, and show the same medication inclusion and billing basis before treating the two offers as equivalent.

When this offer belongs on the shortlist: bmiMD NAD+ injection

bmiMD's listing answers the basic commercial question for NAD+ injection, but it cannot answer personal eligibility, medical fit, pharmacy assignment, or an individual outcome. Those limits belong in the decision, not in fine print after it.

Readers considering injectable NAD through bmiMD who need the injection's price basis kept separate from the nasal spray. Treat the provider link as a verification step: confirm the product name, price phase, medication inclusion, state rule, pharmacy, renewal date, and refund boundary before payment.

Common questions

bmiMD NAD+ injection FAQ

What is the price for this treatment for bmiMD NAD+ injection?
The linked price source lists $159 a month, continuing for NAD+ injection, checked 25 October 2026. The amount should be read with any introduction, prepayment, or commitment shown in the same offer record. It is a dated published commercial fact, not a promise that every checkout configuration, future renewal, or product change will cost the same amount.
Is medication part of that number in the bmiMD figure?
The published bmiMD offer includes medication for NAD+ injection. That does not establish that the price includes labs, every consultation, supplies, faster shipping, dose-related price changes, or a future refill. Confirm those items and the complete charge in the selected checkout before treating the figure as all-inclusive.
Do these details apply to other formats for bmiMD NAD+ injection?
This guide covers NAD+ injection in Injection format. It does not transfer price, regulatory status, evidence, convenience, dosing, pharmacy, or fulfillment claims to another NAD+ injection formulation or to a related product. Compare route and product identity before comparing the price because similar medication names can still describe materially different offers.
Does missing state information mean nationwide service for bmiMD NAD+ injection?
Nationwide availability has not been verified for this offer. Confirm current state eligibility before relying on the offer. A published state list is only one part of eligibility. bmiMD must also confirm clinician licensure, product eligibility, and pharmacy fulfillment for the specific NAD+ injection prescription. Completing an intake does not guarantee approval, dispensing, or a particular outcome.
Which page ranks alternatives for bmiMD NAD+ injection?
Use the NAD+ injection comparison to check the dated prices, product formats and plan terms across providers. Compare bmiMD only with offers that disclose the same price components, medication inclusion, commitment, and format; otherwise explain why the rows are not directly equivalent.

Sources and method

Telehealth Ledger checked provider pages, plan terms, and independent context on 25 October 2026. This page compares published commercial terms. It is not a rating, medical advice, or a guarantee that a clinician will prescribe treatment.